Alembic Pharmaceuticals Limited

• Pradeep Jain Appointed Associate Vice President – Accounts & Finance at Alembic Pharmaceuticals
  https://hrtoday.in/ · 23 Oct 2026
• Alembic Pharmaceuticals Gets USFDA Final Approval For Ear Infection Drug
  BW Healthcare World · 20 Oct 2026
• Alembic gets FDA nod for drug to treat bacterial infections
  pharma.economictimes.indiatimes.com · 19 Oct 2026
• Alembic Pharma gets USFDA approval for otic suspension selling $110M yearly
  scanx.trade · 19 Oct 2026
• Alembic Pharmaceuticals Receives USFDA Approval for Ear
  Passionate In Marketing · 19 Oct 2026
• Alembic Pharma receives USFDA approval for generic ear infection drug
  Business Standard · 19 Oct 2026
• Alembic Pharma gets USFDA nod for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%
  Express Pharma · 19 Oct 2026
• Alembic Pharmaceuticals Receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Ear Suspension
  Machine Maker · 19 Oct 2026
• Alembic Pharma Bags USFDA Approval for USD 110 Million Generic Ear Infection Drug
  Medical Dialogues · 18 Oct 2026
• Alembic Pharma secures USFDA approval for ear infection suspension
  Indian Pharma Post · 17 Oct 2026
• Alembic Pharmaceuticals Receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Otic Suspension 0.3%/0.1%
  Sahi · 17 Oct 2026
• Alembic Pharmaceuticals (APLLTD.NS) Slips 3.02% to ₹835.45 as Shares Retreat Toward Key Support Zone - Growth Stock Picks
  https://www.siam.in/ · 30 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →